Metric Analysis: Cns Pharmaceuticals Inc (CNSP)’s Key Ratios in the Limelight

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Cns Pharmaceuticals Inc (NASDAQ: CNSP) closed at $0.14 up 9.68% from its previous closing price of $0.13. In other words, the price has increased by $9.68 from its previous closing price. On the day, 13.67 million shares were traded. CNSP stock price reached its highest trading level at $0.149 during the session, while it also had its lowest trading level at $0.1308.

Ratios:

For a deeper understanding of Cns Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.31 and its Current Ratio is at 0.31.

On August 24, 2020, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $11.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 01 ’24 when Gumulka Jerzy bought 33,333 shares for $0.30 per share. The transaction valued at 10,000 led to the insider holds 43,006 shares of the business.

Evans Carl Anthony bought 33,333 shares of CNSP for $10,000 on Feb 01 ’24. The Director now owns 33,458 shares after completing the transaction at $0.30 per share. On Feb 01 ’24, another insider, Downs Christopher, who serves as the Chief Financial Officer of the company, bought 66,666 shares for $0.30 each. As a result, the insider paid 20,000 and bolstered with 103,438 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNSP now has a Market Capitalization of 4661228 and an Enterprise Value of 3292917.

Stock Price History:

Over the past 52 weeks, CNSP has reached a high of $137.50, while it has fallen to a 52-week low of $0.10. The 50-Day Moving Average of the stock is 1.31%, while the 200-Day Moving Average is calculated to be -98.20%.

Shares Statistics:

For the past three months, CNSP has traded an average of 15.04M shares per day and 70333950 over the past ten days. A total of 33.45M shares are outstanding, with a floating share count of 32.84M. Insiders hold about 1.81% of the company’s shares, while institutions hold 0.43% stake in the company. Shares short for CNSP as of 1728950400 were 1114751 with a Short Ratio of 0.07, compared to 1726185600 on 364584. Therefore, it implies a Short% of Shares Outstanding of 1114751 and a Short% of Float of 3.47.

Most Popular